AT297021B - Verfahren zur Herstellung neuer Xanthinverbindungen - Google Patents

Verfahren zur Herstellung neuer Xanthinverbindungen

Info

Publication number
AT297021B
AT297021B AT682270A AT682270A AT297021B AT 297021 B AT297021 B AT 297021B AT 682270 A AT682270 A AT 682270A AT 682270 A AT682270 A AT 682270A AT 297021 B AT297021 B AT 297021B
Authority
AT
Austria
Prior art keywords
production
xanthine compounds
new xanthine
new
compounds
Prior art date
Application number
AT682270A
Other languages
English (en)
Original Assignee
Parke Davis & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis & Co filed Critical Parke Davis & Co
Application granted granted Critical
Publication of AT297021B publication Critical patent/AT297021B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/12Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1, 3, and 7, e.g. caffeine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT682270A 1969-07-30 1970-07-27 Verfahren zur Herstellung neuer Xanthinverbindungen AT297021B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84626469A 1969-07-30 1969-07-30
US4559470A 1970-06-11 1970-06-11

Publications (1)

Publication Number Publication Date
AT297021B true AT297021B (de) 1972-03-10

Family

ID=26722972

Family Applications (1)

Application Number Title Priority Date Filing Date
AT682270A AT297021B (de) 1969-07-30 1970-07-27 Verfahren zur Herstellung neuer Xanthinverbindungen

Country Status (8)

Country Link
AT (1) AT297021B (de)
BE (1) BE754007A (de)
CA (1) CA929519A (de)
CH (2) CH512486A (de)
DE (1) DE2037171C3 (de)
FR (1) FR2059577B1 (de)
GB (1) GB1280424A (de)
NL (1) NL7011094A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2093403C (en) * 1992-04-08 1999-08-10 Fumio Suzuki Therapeutic agent for parkinson's disease
US5484920A (en) * 1992-04-08 1996-01-16 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for Parkinson's disease
JP2613355B2 (ja) * 1992-09-28 1997-05-28 協和醗酵工業株式会社 パーキンソン氏病治療剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317533A (en) * 1967-05-02 Theophylline derivatives

Also Published As

Publication number Publication date
FR2059577A1 (de) 1971-06-04
DE2037171A1 (de) 1971-02-18
GB1280424A (en) 1972-07-05
CH512486A (fr) 1971-09-15
NL7011094A (de) 1971-02-02
BE754007A (fr) 1970-12-31
DE2037171C3 (de) 1978-05-18
CH512487A (fr) 1971-09-15
DE2037171B2 (de) 1977-09-22
CA929519A (en) 1973-07-03
FR2059577B1 (de) 1973-08-10

Similar Documents

Publication Publication Date Title
CH539012A (de) Verfahren zur Herstellung neuer Phenoxyalkancarbonsäuren
AT311315B (de) Verfahren zur Herstellung neuer Alkoxydinitroaniline
AT326674B (de) Verfahren zur herstellung neuer naphthyridinderivaten
AT309696B (de) Verfahren zur Herstellung neuer D-Arabinofuranosylpurinderivate
CH536803A (de) Verfahren zur Herstellung neuer Naphthylpropionsäuren
CH530984A (de) Verfahren zur Herstellung neuer Hexahydrobenzazocine
AT306256B (de) Verfahren zur Herstellung neuer Benzomorphanderivate
CH537895A (de) Verfahren zur Herstellung neuer Hydroxycrotonsäuren
AT303272B (de) Verfahren zur Herstellung neuer Evomonosid-Derivate
CH535730A (de) Verfahren zur Herstellung neuer Naphthylalkanole
CH530988A (de) Verfahren zur Herstellung neuer Diallylaminoalkanoylamide
AT299916B (de) Verfahren zur Herstellung neuer bis-Aminobenzoate
CH516591A (de) Verfahren zur Herstellung neuer Thiazolopyrrolopyrimidine
AT297021B (de) Verfahren zur Herstellung neuer Xanthinverbindungen
AT305266B (de) Verfahren zur Herstellung neuer substituierter 2-Benzylphenole
AT295512B (de) Verfahren zur Herstellung neuer Pyrrolderivate
AT301036B (de) Verfahren zur Herstellung neuer Neriifolin-Derivate
CH498817A (de) Verfahren zur Herstellung neuer Isothiocyanato-diphenylamine
AT319914B (de) Verfahren zur Herstellung neuer Triazapentadiene
CH511886A (de) Verfahren zur Herstellung neuer Furanonderivate
CH538461A (de) Verfahren zur Herstellung neuer 18-Methyl-5a-H-androstane
AT299176B (de) Verfahren zur Herstellung neuer Hexahydrophenanthrenderivate
CH497402A (de) Verfahren zur Herstellung neuer Isothiocyanato-N-alkanoyl-diphenylamine
AT299941B (de) Verfahren zur Herstellung neuer Thiazolderivate
CH515219A (de) Verfahren zur Herstellung neuer Harnstoffe

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee